Weight loss reduces breast ductal fluid estrogens in obese postmenopausal women: A single arm intervention pilot study

Nutrition Journal

Volumn 11, Issue 1, 2012, Pages

  Carpenter, Catherine L ^a,b   Duvall, Karen ^c   Jardack, Patricia ^c   Li, Luyi ^a   Henning, Susanne M ^a   Li, Zhaoping ^a   Heber, David ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Breast cancer; Breast ductal fluid; Diet; Exercise; Obesity; Postmenopausal

Indexed keywords

ESTRADIOL; ESTROGEN; ESTRONE SULFATE; INTERLEUKIN 6; LEPTIN;

ADULT; AEROBIC EXERCISE; ANTHROPOMETRY; ARTICLE; BODY COMPOSITION; BODY MASS; BREAST DUCT; CLINICAL ARTICLE; DIET THERAPY; DUAL ENERGY X RAY ABSORPTIOMETRY; ESTROGEN BLOOD LEVEL; EXERCISE INTENSITY; FAT MASS; FEMALE; HUMAN; KINESIOTHERAPY; LEAN BODY WEIGHT; MUSCLE MASS; MUSCLE STRENGTH; OBESITY; OXYGEN CONSUMPTION; PHLEBOTOMY; POSTMENOPAUSE; WEIGHT REDUCTION;

ABSORPTIOMETRY, PHOTON; BIOLOGICAL MARKERS; BODY COMPOSITION; BODY MASS INDEX; DIET; DIET, REDUCING; DIETARY CARBOHYDRATES; DIETARY FATS; DIETARY PROTEINS; ESTRADIOL; ESTROGENS; ESTRONE; EXERCISE; FATTY ACIDS; FEASIBILITY STUDIES; FEMALE; FRUIT; HUMANS; INTERLEUKIN-6; INTERVENTION STUDIES; LEPTIN; MIDDLE AGED; OBESITY; OXYGEN CONSUMPTION; PHLEBOTOMY; PILOT PROJECTS; POSTMENOPAUSE; VEGETABLES; WEIGHT LOSS;

EID: 84870341539     PISSN: None     EISSN: 14752891     Source Type: Journal    
DOI: 10.1186/1475-2891-11-102     Document Type: Article

References (44)

1. Inflammation and increased aromatase expression occur in the breast tissue of obese women with breast cancer. Morris PG, Hudis CA, Giri D, Morrow M, Falcone DJ, Zhao XK, Du B, Brogi E, Crawford CB, Kopelovich L, Subbaramaiah K, Dannenberg AJ, Cancer Prev Res 2011 4 1021 1029 10.1158/1940-6207.CAPR-11-0110
2. Microenvironmental influences that drive progression from benign breast disease to invasive breast cancer. Cichon MA, Degnim AC, Visscher DW, Radisky DC, J Mammary Gland Biol Neoplasia 2010 15 389 397 10.1007/s10911-010-9195-8 21161341
3. Estrogens, progestogens, normal breast cell proliferation, and breast cancer risk. Pike MC, Spicer DV, Dahmoush L, Press MF, Epidemiol Rev 1993 15 17 35 8405201 (Pubitemid 23269068)
4. Histological and biological evolution of human premalignant breast disease. Allred DC, Mohsin SK, Fuqua SA, Endocr Relat Cancer 2001 8 47 61 10.1677/erc.0.0080047 11350726 (Pubitemid 32520253)
5. Cytologic evaluation of breast fluid in the detection of breast disease. Sartorius OW, Smith HS, Morris P, Benedict D, Friesen L, J Natl Cancer Inst 1977 59 1073 1080 903989 (Pubitemid 8224271)
6. Mitogenic growth factors in breast fluid obtained from healthy women: evaluation of biological and extraneous sources of variability. Gann P, Chatterton R, Vogelsong K, Dupuis J, Ellman A, Cancer Epidemiol Biomark Prev 1997 6 421 428 (Pubitemid 27270546)
7. Association of breast fluid coloration with age, ethnicity, and cigarette smoking. Petrakis NL, Miike R, King EB, Lee L, Mason L, Chang-Lee B, Breast Cancer Res Treat 1988 11 255 262 10.1007/BF01807284 3167231
8. Prostate-specific antigen levels in nipple aspirate fluid correlate with breast cancer risk. Sauter ER, Daly M, Linahan K, Ehya H, Engstrom PF, Bonney G, Ross EA, Yu H, Diamandis E, Cancer Epidemiol Biomark Prev 1996 5 967 970 (Pubitemid 26415868)
9. Modulation of serum and breast ductal fluid lipids by a very-low-fat, high fiber diet in premenopausal women. Bagga D, Ashley JM, Geffrey S, Wang HJ, Barnard J, Elashoff R, Heber D, J Natl Cancer Inst 1994 86 1419 1421 10.1093/jnci/86.18.1419 8072037 (Pubitemid 2151508)
10. Pooled analysis of prospective cohort studies on height, weight, and breast cancer risk. van den Brandt PA, Spiegelman D, Yuan SS, Adami HO, Beeson L, Folsom AR, Fraser G, Goldbohm RA, Graham S, Kushi L, Marshall JR, Miller AB, Rohan T, Smith-Warner SA, Speizer FE, Willett WC, Wolk A, Hunter DJ, Am J Epidemiol 2000 152 514 527 10.1093/aje/152.6.514 10997541
11. Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies. Key T, Appleby P, Barnes I, Reeves G, Endogenous Hormones and Breast Cancer Collaborative Group, J Natl Cancer Inst 2002 94 606 616 10.1093/jnci/94.8.606 11959894 (Pubitemid 34498648)
12. Effect of family history, obesity, and exercise on breast cancer risk among postmenopausal women. Carpenter CL, Ross RK, Paganini-Hill A, Bernstein L, Int J Cancer 2003 106 96 102 10.1002/ijc.11186 12794763 (Pubitemid 36750394)
13. Million Women study collaboration. Cancer incidence and mortality in relation to body mass index in the million women study: cohort study. Reeves GK, Pirie K, Beral V, Green J, Spencer E, Bull D, BMJ 2007 335 1134 1144 10.1136/bmj.39367.495995.AE 17986716 (Pubitemid 350247286)
14. Oxidative stress, obesity and breast cancer risk: results from the Shanghai Women's Health Study. Dai Q, Gao YT, Shu XO, Yang G, Milne G, Cai Q, Wen W, Rothman N, Cai H, Li H, Xiang Y, Chow WH, Zheng W, J Clin Oncol 2009 27 2482 2488 10.1200/JCO.2008.19.7970 19380446
15. Molecular links between obesity and breast cancer. Lorincz AM, Sukumar S, Endocr Relat Cancer 2006 13 279 292 10.1677/erc.1.00729 16728564 (Pubitemid 43886659)
16. Adiposity, the metabolic syndrome, and breast cancer in African-American and White American women. Rose DP, Haffner SM, Baillargeon J, Endocr Rev 2007 28 763 777 10.1210/er.2006-0019 17981890 (Pubitemid 350294295)
17. Minireview: obesity and breast cancer: the estrogen connection. Cleary MP, Grossmann ME, Endocrinology 2009 150 2537 2542 10.1210/en.2009-0070 19372199
18. Aromatase excess in cancers of breast, endometrium and ovary. Bulun SE, Chen D, Lu M, Zhao H, Cheng Y, Demura M, Yilmaz B, Martin R, Utsunomiya H, Thung S, Su E, Marsh E, Hakin A, Yin P, Ishikawa H, Amin S, Imir G, Gurates B, Attar E, Reierstad S, Innes J, Lin Z, J Steroid Biochem Mol Biol 2007 106 81 96 10.1016/j.jsbmb.2007.05.027 17590327 (Pubitemid 47362640)
19. Aromatase and the breast: regulation and clinical aspects. Miller WR, Maturitas 2006 54 335 341 10.1016/j.maturitas.2006.04.020 16730141
20. Effect of exercise on serum estrogens in postmenopausal women: a 12-month randomized clinical trial. McTiernan A, Tworoger SS, Ulrich CM, Yasui Y, Irwin ML, Rajan KB, Sorensen B, Rudolph RE, Bowen D, Stanczyk FZ, Potter JD, Schwartz RS, Cancer Res 2004 64 2923 2928 10.1158/0008-5472.CAN-03-3393 15087413 (Pubitemid 38500634)
21. Exercise effect on oxidative stress is independent of change in estrogen metabolism. Schmitz KH, Warren M, Rundle AG, Williams NI, Gross MD, Kurzer MS, Cancer Epidemiol Biomark Prev 2008 17 220 223 10.1158/1055-9965.EPI-07-0058 (Pubitemid 351196294)
22. Effects of low-fat and/or high fruit-and-vegetable diets on plasma levels of 8-isoprostane-F2alpha in the nutrition and breast health study. Chen G, Heilbrun LK, Venkatramanamoorthy R, Maranci V, Redd JN, Klurfeld DM, Djuric Z, Nutr Cancer 2004 50 155 160 10.1207/s15327914nc5002-4 15623461
23. Effect of diet and exercise intervention on inflammatory and adhesion molecules in postmenopausal women on hormone replacement therapy and at risk for coronary artery disease. Wegge JK, Roberts CK, Ngo TH, Barnard RJ, Metabolism 2004 53 377 381 10.1016/j.metabol.2003.10.016 15015151 (Pubitemid 38684699)
24. Influence of vitamin a on human colostrum and early milk. Ajans ZA, Sarrif A, Husbands M, Am J Clin Nutr 1965 17 139 142 5889786
25. beta-Carotene in breast milk and serum is increased after a single beta-carotene dose. Canfield LM, Giuliano AR, Nielson EM, Yap HH, Graver EJ, Cui HA, Blashill BM, Am J Clin Nutr 1997 66 52 61 9209169 (Pubitemid 27278899)
26. Non-steroidal anti-inflammatory drug (NSAID) use and levels of a lipid oxidation marker in plasma and nipple aspirate fluids. Kato I, Chen G, Djuric Z, Breast Cancer Res Treat 2006 97 145 148 10.1007/s10549-005-9102-y 16322889
27. C-reactive protein in nipple aspirate fluid associated with Gail model factors. Lithgow D, Nyamathi A, Elashoff D, Martinez-Maza O, Covington C, Biol Res Nurs 2007 9 108 116 10.1177/1099800407306426 17909163
28. Endocrine biomarkers in ductal lavage samples from women at high risk for breast cancer. Bhandare D, Nayar R, Bryk M, Hou N, Cohn R, Golewale N, Parker NP, Chatterton RT, Rademaker A, Khan SA, Cancer Epidemiol Biomark Prev 2005 14 2620 2627 10.1158/1055-9965.EPI-05-0302 (Pubitemid 41752724)
29. Love/Avon Army of Women: Closed Projects, http://researchers.armyofwomen. org/Closed-Projects
30. American College of Sports Medicine, ACSM's guidelines for exercise testing and prescription Philadelphia, PA: Lippincott Williams & Wilkins 7th 2006 23254274
31. Strength testing: predicting a one-rep max from reps-to-fatigue. Brzycki M, J Health Phys Educ Rec Dance 1993 64 88 90
32. Dietary modulation of omega-3/omega-6 polyunsaturated fatty acid ratios in patients with breast cancer. Bagga D, Capone S, Wang HJ, Heber D, Lill M, Chap L, Glaspy JA, J Nat Cancer Inst 1997 89 1123 1131 10.1093/jnci/89.15.1123 9262250 (Pubitemid 27337926)
33. Optimisation of derivatisation for the analysis of estrogenic compounds in water by solid-phase extraction gas chromatography-mass spectrometry. Zhang ZL, Hibberd A, Zhou JL, Anal Chim Acta 2006 577 52 61 10.1016/j.aca.2006.06.029 17723653
34. Body weight, body composition, and calorie status. Grande F, Keys A, Modern nutrition in health and disease Philadelphia: Lea & Febiger, Goodhard RS, Shills ME, 27th 1980
35. American Heart Association, Exercise testing and training of apparently healthy individuals: a handbook for physicians Dallas, TX: American Heart Association 1972
36. Cooper CB, Storer TW, Exercise testing and interpretation, a practical approach Cambridge, UK: Cambridge University Press 2001
37. Exercise attenuates the weight-loss-induced reduction in muscle mass in frail obese older adults. Frimel TN, Sinacore DR, Villareal DT, Med Sci Sports Exerc 2008 40 1213 1219 10.1249/MSS.0b013e31816a85ce 18580399
38. Moderate exercise attenuates the loss of skeletal muscle mass that occurs with intentional caloric restriction-induced weight loss in older, overweight to obese adults. Chomentowski P, Dube JJ, Amati F, Stefanovic-Racic M, Zhu S, Toledo FGS, Goodpaster BH, J Gerontol 2009 64 575 580
39. Body fat, energy balance and estradiol levels: a study based on hormonal profiles from complete menstrual cycles. Ziomkiewicz A, Ellison PT, Lipson SF, Thune I, Jasienska G, Hum Reprod 2008 11 2555 2563
40. Breast-tissue sampling for risk assessment and prevention. Fabian CJ, Kimler BF, Mayo MS, Khan SA, Endocr Relat Cancer 2005 12 185 213 10.1677/erc.1.01000 15947097 (Pubitemid 40903084)
41. Measurement of sex steroid hormones in breast adipocytes: methods and implications. Falk RT, Gentzschein E, Stanczyk FZ, Brinton LA, Garcia-Closas M, Ioffe OB, Sherman ME, Cancer Epidemiol Biomark Prev 2008 17 1891 1895 10.1158/1055-9965.EPI-08-0119
42. Breast cancer risk in women with abnormal cytology in nipple aspirates of breast fluid. Wrensch MR, Petrakis NL, Miike R, King EB, Chew K, Neuhaus J, Lee MM, Rhys M, J Natl Cancer Inst 2001 93 1791 1798 10.1093/jnci/93.23.1791 11734595 (Pubitemid 33150451)
43. Ductal lavage for detection of cellular atypia in women at high risk for breast cancer. Dooley WC, Ljung BM, Veronesi U, Cazzaniga M, Elledge RM, O'Shaughnessy JA, Kuerer HM, Hung DT, Khan SA, Phillips RF, Ganz PA, Euhus DM, Esserman LJ, Haffty BG, King BL, Kelley MC, Anderson MM, Schmit PJ, Clark RR, Kass FC, Anderson BO, Troyan SL, Arias RD, Quiring JN, Love SM, Page DL, King EB, J Natl Cancer Inst 2001 93 1624 1632 10.1093/jnci/93.21.1624 11698566 (Pubitemid 33094869)
44. Patterns of sex steroid hormones in nipple aspirate fluid during the menstrual cycle and after menopause in relation to serum concentrations. Chatterton RT, Khan SA, Heinz R, Ivancic D, Lee O, Cancer Epidemiol Biomark Prev 2010 19 275 279 10.1158/1055-9965.EPI-09-0381